Macular Edema, Cystoid Completed Phase 4 Trials for Dextran (DB09255)

Also known as: Cystoid Macular Edema / Cystoid macular oedema / Cystoid macular edema (disorder)

Indication	Status	Phase
DBCOND0027867 (Macular Edema, Cystoid)	Completed	4

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT01978015	Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG	Treatment	Bimatoprost (DB00905) Dextran (DB09255) Hypromellose (DB11075) Latanoprost (DB00654) Timolol (DB00373) Travoprost (DB00287)